Pharming Group N.V.
Joenja
APDS
Resolved
103days ago
Approval decision · Mar 26, 2026
What's at stake
A final FDA approval decision on Joenja for APDS is expected Mar 26, 2026.
Primary source
· SEC 6-K
verified 12h ago
“the Japanese Ministry of Health, Labour and Welfare (MHLW) granted marketing authorization for Joenja® for the treatment of APDS in adult and pediatric patients aged 4 years and older.”